Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide

Karl G. Braslis, Richard C. David, Eustos Nelson, Francisco Civantos, Mark S Soloway

Research output: Contribution to journalArticle

25 Scopus citations

Abstract

We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.

Original languageEnglish (US)
Pages (from-to)329-331
Number of pages3
JournalUrology
Volume45
Issue number2
DOIs
StatePublished - Feb 1995

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide'. Together they form a unique fingerprint.

  • Cite this